Fulgent Genetics
FLGT
126 hedge funds and large institutions have $321M invested in Fulgent Genetics in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 13 closing their positions.
308% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 13
204% more capital invested
Capital invested by funds: $106M → $321M (+$215M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
47% more funds holding
Funds holding: 86 → 126 (+40)
24% more call options, than puts
Call options by funds: $8.51M | Put options by funds: $6.85M
10% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 29
6.4% more ownership
Funds ownership: 30.16% → 36.56% (+6.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.5M |
| 2 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
+$14.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$11.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.03M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$5.59M |
| 2 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$4.02M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$3.71M |
| 4 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$3.3M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$2.78M |
FLGT Hedge Fund Activity: Q3 2020 in Review
126 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2020, worth a combined $321M — up 204% from $106M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new FLGT positions and 13 closed out — a net gain of 40 holders — while 32 added to existing stakes and 29 trimmed.
The largest buyer was BlackRock, adding an estimated $27.5M. The largest seller was Bank of Montreal, cutting an estimated $5.59M.
- 126 institutional investors held Fulgent Genetics (FLGT) as of Q3 2020, up from 86 in Q2 2020.
- Funds reported $321M of Fulgent Genetics stock for Q3 2020, up 204% quarter-over-quarter.
- 53 funds opened new Fulgent Genetics positions in Q3 2020 and 13 closed out, a net change of +40 holders.
- The largest Fulgent Genetics buyer in Q3 2020 was BlackRock, an estimated $27.5M added.
- The largest Fulgent Genetics seller in Q3 2020 was Bank of Montreal, an estimated $5.59M sold.
Based on aggregated 13F filings for Q3 2020.